Cheddar News
146

Humacyte Goes Public Through SPAC Merger

Humacyte, a biotech company developing universally implantable human tissue, has gone public through a merger with special purpose acquisition company Alpha Healthcare Acquisition Corp. Dr. Laura Niklason, Founder, President and CEO of Humacyte, tells Cheddar what this means to her and how the merger will help propel Humacyte's cutting edge work forward.

Latest News

Business & Tech

Politics